Nanjing King-friend Biochemical Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 7.42% vs -12.79% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 10.67% vs -41.49% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "997.60",
          "val2": "928.70",
          "chgp": "7.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "160.80",
          "val2": "153.30",
          "chgp": "4.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.50",
          "val2": "16.40",
          "chgp": "-5.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.40",
          "val2": "28.90",
          "chgp": "-88.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "98.50",
          "val2": "89.00",
          "chgp": "10.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "104.80%",
          "val2": "104.40%",
          "chgp": "0.04%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.50% vs 0.91% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -29.61% vs 536.17% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,969.90",
          "val2": "3,911.10",
          "chgp": "1.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "971.30",
          "val2": "1,147.40",
          "chgp": "-15.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "57.80",
          "val2": "78.00",
          "chgp": "-25.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "41.40",
          "val2": "-18.80",
          "chgp": "320.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "581.50",
          "val2": "826.10",
          "chgp": "-29.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "183.40%",
          "val2": "248.60%",
          "chgp": "-6.52%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

997.60

928.70

7.42%

Operating Profit (PBDIT) excl Other Income

160.80

153.30

4.89%

Interest

15.50

16.40

-5.49%

Exceptional Items

3.40

28.90

-88.24%

Consolidate Net Profit

98.50

89.00

10.67%

Operating Profit Margin (Excl OI)

104.80%

104.40%

0.04%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 7.42% vs -12.79% in Mar 2026

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is 10.67% vs -41.49% in Mar 2026

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,969.90

3,911.10

1.50%

Operating Profit (PBDIT) excl Other Income

971.30

1,147.40

-15.35%

Interest

57.80

78.00

-25.90%

Exceptional Items

41.40

-18.80

320.21%

Consolidate Net Profit

581.50

826.10

-29.61%

Operating Profit Margin (Excl OI)

183.40%

248.60%

-6.52%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 1.50% vs 0.91% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -29.61% vs 536.17% in Dec 2024

All Annual Results